Inflammatory MBC Treatments
Learn more about inflammatory breast cancer and its treatments.Â
Theragnostics
Learn about theragnostics, how it works, and its potential in metastatic breast cancer.
Atezolizumab Immunotherapy Is Withdrawn From FDA-Approval Process
Understand more about the change in approval for Atezolizumab (Tecentriq®) for TNBC.
Cell-Based Therapies: A Type of Immunotherapy for MBC
What is the difference between CAR T-cell therapy, TCR therapy, TIL therapy, NK cell therapy, and Bria-IMT? Learn more here.
Cell-Based Therapies: A Type of Immunotherapy for MBC
What is the difference between CAR T-cell therapy, TCR therapy, TIL therapy, NK cell therapy, and Bria-IMT? Learn more here.
Update on Oral SERDs for Estrogen Receptor-Positive MBC
Learn about oral SERDs in clinical trials for ER+ MBC.
Y-90 Internal Radiation Therapy for Liver Mets
Local therapy is important for managing symptoms related to MBC with liver mets. Learn how Yttrium-90 internal radiation therapy (Y-90) may increase survival.
The Latest Research on Hormone Receptor-Positive (HR+) MBC
Learn about research on HR+ MBC treatment, including AKT inhibitors, oral SERDs, CDK 4/6 inhibitors, and more.
2021 Update on Metastatic Triple Negative Breast Cancer Treatment
Treatment options for triple negative breast cancer are increasing. Learn about what’s available now and what’s being studied in clinical trials.
Treating Breast Cancer Brain Mets
Read further for an overview of current research and new therapies for breast cancer brain metastasis (BCBM).